These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37312181)

  • 1. Patients' satisfaction with heroin-assisted treatment: a qualitative study.
    Ellefsen R; Wüsthoff LEC; Arnevik EA
    Harm Reduct J; 2023 Jun; 20(1):73. PubMed ID: 37312181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of heroin-assisted treatment in Norway: protocol for a mixed methods study.
    Myklebust LH; Eide D; Arnevik EA; Dadras O; De Pirro S; Ellefsen R; Fadnes LT; Hesse M; Kvamme TL; Melis F; Oldervoll A; Thylstrup B; Wusthoff LEC; Clausen T
    BMC Health Serv Res; 2024 Mar; 24(1):398. PubMed ID: 38553691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'This is hardcore': a qualitative study exploring service users' experiences of Heroin-Assisted Treatment (HAT) in Middlesbrough, England.
    Riley F; Harris M; Poulter HL; Moore HJ; Ahmed D; Towl G; Walker T
    Harm Reduct J; 2023 May; 20(1):66. PubMed ID: 37173697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting.
    Klimas J; Dong H; Fairbairn N; Socías E; Barrios R; Wood E; Kerr T; Montaner J; Milloy MJ
    Addict Sci Clin Pract; 2018 Feb; 13(1):3. PubMed ID: 29409539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heroin assisted treatment for key health outcomes in people with chronic heroin addictions: A context-focused systematic review.
    McNair R; Monaghan M; Montgomery P
    Drug Alcohol Depend; 2023 Jun; 247():109869. PubMed ID: 37086659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More than just 'free heroin': Caring whilst navigating constraint in the delivery of diamorphine assisted treatment.
    Poulter HL; Walker T; Ahmed D; Moore HJ; Riley F; Towl G; Harris M
    Int J Drug Policy; 2023 Jun; 116():104025. PubMed ID: 37062231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study.
    Vogel M; Meyer M; Westenberg JN; Kormann A; Simon O; Salim Hassan Fadlelseed R; Kurmann M; Bröer R; Devaud N; Sanwald U; Baumgartner S; Binder H; Strasser J; Krausz RM; Beck T; Dürsteler KM; Falcato L
    Harm Reduct J; 2023 Jan; 20(1):2. PubMed ID: 36611162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility, safety, and acceptability of intranasal heroin-assisted treatment in Switzerland: protocol for a prospective multicentre observational cohort study.
    Westenberg JN; Meyer M; Strasser J; Krausz M; Dürsteler KM; Falcato L; Vogel M
    Addict Sci Clin Pract; 2023 Mar; 18(1):15. PubMed ID: 36906604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal Opioid Agonist Treatment in Patients with Severe Opioid Dependence: A Case Series.
    Vogel M; Köck P; Strasser J; Kalbermatten C; Binder H; Dürsteler KM; Walter M; Falcato L; Krausz M; Kormann A
    Eur Addict Res; 2022; 28(1):80-86. PubMed ID: 34311466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cocaine contingency management in heroin-assisted treatment: Results of a randomized controlled trial.
    Blanken P; Hendriks VM; Huijsman IA; van Ree JM; van den Brink W
    Drug Alcohol Depend; 2016 Jul; 164():55-63. PubMed ID: 27177805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problematizing the DSM-5 criteria for opioid use disorder: A qualitative analysis.
    Boyd S; Ivsins A; Murray D
    Int J Drug Policy; 2020 Apr; 78():102690. PubMed ID: 32278265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial.
    Oviedo-Joekes E; Guh D; Brissette S; Marchand K; MacDonald S; Lock K; Harrison S; Janmohamed A; Anis AH; Krausz M; Marsh DC; Schechter MT
    JAMA Psychiatry; 2016 May; 73(5):447-55. PubMed ID: 27049826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telling our stories: heroin-assisted treatment and SNAP activism in the Downtown Eastside of Vancouver.
    Boyd S; Murray D; ; MacPherson D
    Harm Reduct J; 2017 May; 14(1):27. PubMed ID: 28521781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. «One prick and then it´s done»: a mixed-methods exploratory study on intramuscular injection in heroin-assisted treatment.
    Meyer M; Eichenberger R; Strasser J; Dürsteler KM; Vogel M
    Harm Reduct J; 2021 Dec; 18(1):134. PubMed ID: 34922561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-methods and longitudinal study of patients' perceptions in injectable opioid agonist treatment: Implications for advancing patient-centered methodologies in substance use research.
    Marchand K; Palis H; Guh D; Lock K; MacDonald S; Brissette S; Marsh DC; Harrison S; Schechter MT; Oviedo-Joekes E
    J Subst Abuse Treat; 2022 Jan; 132():108512. PubMed ID: 34098207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does heroin-assisted treatment reduce crime? A review of randomized-controlled trials.
    Smart R; Reuter P
    Addiction; 2022 Mar; 117(3):518-531. PubMed ID: 34105206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the COVID-19 pandemic-Is an update of legal restrictions warranted?
    Meyer M; Strasser J; Köck P; Walter M; Vogel M; Dürsteler KM
    Int J Drug Policy; 2022 Mar; 101():103548. PubMed ID: 34920218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence.
    Oviedo-Joekes E; Palis H; Guh D; Marchand K; Brissette S; Lock K; MacDonald S; Harrison S; Anis AH; Krausz M; Marsh DC; Schechter MT
    Drug Alcohol Rev; 2018 Jan; 37(1):137-146. PubMed ID: 28593748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The suitability of oral diacetylmorphine in treatment-refractory patients with heroin dependence: A scoping review.
    F Martins ML; Wilthagen EA; Oviedo-Joekes E; Beijnen JH; de Grave N; Uchtenhagen A; Beck T; Van den Brink W; Schinkel AH
    Drug Alcohol Depend; 2021 Oct; 227():108984. PubMed ID: 34482044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effects beyond cocaine use of sustained-release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: secondary analysis of a double-blind, placebo-controlled randomized trial.
    Blanken P; Nuijten M; van den Brink W; Hendriks VM
    Addiction; 2020 May; 115(5):917-923. PubMed ID: 31908066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.